Layne Norton challenges insulin as obesity’s root cause
The Biolayne episode argues the carbohydrate-insulin model has been oversold, citing controlled feeding research, overfeeding studies and GLP-1 drugs.

Layne Norton used a Biolayne podcast episode published Oct. 26 to challenge claims that insulin causes obesity, saying the hormone’s reputation has worsened over about 15 years.
For listeners weighing low-carb and low-fat claims, the episode’s stake is whether calorie balance remains central when calories and protein are controlled; the podcast points to metabolic ward trials and controlled-feeding meta-analyses.
Norton, of Biolayne, said on the podcast published Oct. 26: “But over the last probably 15 years, I would say that insulin has started to get a really, really bad rap, uh, people claiming it's the cause of obesity, the root of all disease.”
The episode frames the dispute around the carbohydrate-insulin model of obesity, which Norton describes as treating insulin rather than calories as the main driver of fat gain. In the transcript excerpt, he says insulin cannot create energy and “cannot manufacture energy or get rid of thermodynamics.”
Norton said his test for the model is the human evidence, not isolated biochemistry. “I'm saying we need to look at the evidence, examine the evidence, and if this model is robust, then the evidence will support it,” he said.
The episode also revisits older fitness-world claims about insulin. Norton said insulin once had a positive image in bodybuilding circles, where some people used exogenous insulin in the belief that it could support muscle gain. “There is some anecdotal evidence that perhaps injecting exogenous insulin is anabolic,” he said, while adding in the excerpt that he does not recommend exogenous insulin except for people with type 1 diabetes.
Norton specifically introduces “a study from two thousand and fifteen at the NIH where they took people and put them in a metabolic ward.”
The episode summary says Norton discusses low-carb versus low-fat diets when calories and protein are controlled. It also says he uses GLP-1 drugs, which the summary says increase meal-related insulin and produce fat loss, as a challenge to the idea that insulin alone blocks fat loss.
That limits what can be verified from this signal beyond Norton’s stated argument and the topics he covered.
For readers, the episode is best understood as a critique of a popular nutrition claim, not as new clinical evidence. The practical question it raises is narrower than many online debates: whether insulin, by itself, explains fat gain when total energy intake and protein are controlled.
Source: podcast episode, The Dr. Layne Norton Podcast (Biolayne), Oct. 26, 2026.
Atlas360 reports health research and does not provide medical advice.
More stories
- Dietitians advise small swaps for plant-based eating
- TikTok dementia videos mislead in 66.4% of sample, researchers say
- Aberdeen Royal Infirmary faces police inquiry call over 19 deaths
- Bariatric surgery group loses 28.2% after GLP-1 use
- TOFA boosts mouse energy use 18% while preserving muscle
- ICO probes NHS therapy notes accessible to up to 140,000 staff
- Silver diamine fluoride stops decay in over half of baby teeth
- B vitamins can turn urine fluorescent yellow
Latest news
- Hull City 2–0 Brighton: When Resilience Beat Reputation
- David Parr House to honor Victorian art-workman with blue plaque
- Iran's attacks hit 25 tankers near Strait of Hormuz
- FCC approves prison cellphone jamming despite 2.5-mile warning
- Russia strikes Ukraine as Odesa faces electricity strain
- Bahrain reports two injuries after Iranian aerial attacks
- Congress tests Black Democrats' growing policy influence
- Baltic responders fight Sparta II fire after drone strike

